Special Issues
Table of Content

Targeted Therapies and Immunotherapies in Childhood Cancer: Molecular Mechanisms, Drug Resistance, and Biomarkers

Submission Deadline: 28 February 2027 View: 27 Submit to Special Issue

Guest Editor(s)

Prof. Joanna Zawitkowska

Email: joanna.zawitkowska@umlub.edu.pl

Affiliation: Department of Pediatric Hematology, Oncology and Transplantation, Medical University of Lublin, Lublin, Poland

Homepage:

Research Interests: childhood leukemias, anticancer therapy


Assoc. Prof. Małgorzata Mitura-Lesiuk

Email: malgorzata.mitura-lesiuk@umlub.edu.pl

Affiliation: Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland

Homepage:

Research Interests: pediatric oncology, acute lymphoblastic leukemia


Dr. Maciej Dubaj

Email: maciej.dubaj99@gmail.com

Affiliation: Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland

Homepage:

Research Interests: pediatric oncology, miRNAs, acute lymphoblastic leukemia, antibody therapy


Summary

The success of modern pediatric oncology has led to survival rates exceeding 80% in many malignancies. Classic chemotherapy remains an important element, but there are opportunities to further increase cure rates through the use of targeted therapies and immunotherapy. This special issue focuses on the molecular mechanisms underlying childhood cancer development and treatment response.


Topics covered include the identification of potential cancer targets and exploration of novel molecular mechanisms of tumor initiation and metastasis in pediatric malignancies; the development of novel small molecules and targeted therapies; mechanisms of drug sensitivity and cellular resistance; biomarkers of response and/or resistance; pharmacogenetics and pharmacogenomics in pediatric oncology; personalized medicine approaches; the role of cancer stem cells; immunotherapy and clinical immunology; gene therapy; and non-coding RNAs as regulators of cellular gene expression.


Together, these articles aim to advance our understanding of childhood cancer biology and support the development of more effective, mechanism-driven therapeutic strategies.


Keywords

pediatric oncology, targeted therapies, immunotherapy, molecular mechanisms, personalized medicine

Share Link